BridgeMD
New treatment option for Bladder (Urothelial, Transitional Cell) Cancer
Official title MICROBIOTA AND BLADDER CANCER
ClinicalTrials.gov ID: NCT07080333
What this study is testing
What is biopsy?
biopsy is an investigational medicine, being studied as a potential treatment for bladder (urothelial, transitional cell) cancer.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- In France, bladder cancer (BC) is the fourth leading cause of cancer (14,000 new cases per year). It affects older men (\>60 years old) and smoking is the main identified risk factor (RF).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, men only
You may be able to join if
- Age \> 18 years old
- Male
- First RTUV for suspected CV in the presence of macroscopic haematuria or other clinical signs and/or urinary cytology and/or cystoscopy and/or...
- Signed informed consent form
- Affiliation with a social security scheme
You likely can't join if
- Antibiotic use within 3 months prior to inclusion
- Current urinary tract infection (urine culture recommended by the AFU prior to RTUV)
- History of surgical treatment of the urinary and genital tracts within the last 6 months prior to inclusion
- History of RTUV
- History of pelvic radiotherapy
- Interstitial cystitis
See the full eligibility criteria
- Age \> 18 years old
- Male
- First RTUV for suspected CV in the presence of macroscopic haematuria or other clinical signs and/or urinary cytology and/or cystoscopy and/or imaging tests suggestive of CV
- Signed informed consent form
- Affiliation with a social security scheme
- Antibiotic use within 3 months prior to inclusion
- Current urinary tract infection (urine culture recommended by the AFU prior to RTUV)
- History of surgical treatment of the urinary and genital tracts within the last 6 months prior to inclusion
- History of RTUV
- History of pelvic radiotherapy
- Interstitial cystitis
- Patients with an indwelling urinary catheter
- Vulnerable patients: minors, patients under guardianship or curatorship
- Patients with benign tumours after receipt of the pathological report (inverted papilloma, non-tumour inflammatory lesion)
The study team makes the final eligibility decision.
Where it's taking place
- Cannes, France
- Marseille, France
- Menton, France
- Nice, France
- Nîmes, France
- Paris, France
- Rennes, France
- Tours, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cannes, France; Marseille, France; Menton, France; Nice, France; Nîmes, France; Paris, France and 2 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.